{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,7]],"date-time":"2026-08-07T15:41:21Z","timestamp":1786117281913,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T00:00:00Z","timestamp":1785974400000},"content-version":"vor","delay-in-days":370,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100005202","name":"Muscular Dystrophy Association","doi-asserted-by":"publisher","award":["1297954"],"award-info":[{"award-number":["1297954"]}],"id":[{"id":"10.13039\/100005202","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000005","name":"US Department of Defense","doi-asserted-by":"publisher","award":["HT9425-23-1-0461"],"award-info":[{"award-number":["HT9425-23-1-0461"]}],"id":[{"id":"10.13039\/100000005","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Therapy"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/j.ymthe.2025.07.021","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T03:47:43Z","timestamp":1753415263000},"page":"3476-3478","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["NOTCH2 mutation in centronuclear myopathy: Beyond the scope"],"prefix":"10.1016","volume":"33","author":[{"given":"Eric","family":"Tehrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-8078-1027","authenticated-orcid":false,"given":"Atsushi","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ymthe.2025.07.021_bib1","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1016\/j.ymthe.2025.04.041","article-title":"Understanding the role of NOTCH2 mutation in centronuclear myopathy","volume":"33","author":"Lin","year":"2025","journal-title":"Mol. Ther."},{"key":"10.1016\/j.ymthe.2025.07.021_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fphys.2022.984373","article-title":"Implications of notch signaling in duchenne muscular dystrophy","volume":"13","author":"Den Hartog","year":"2022","journal-title":"Front. Physiol."},{"key":"10.1016\/j.ymthe.2025.07.021_bib3","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/ng.995","article-title":"Mutations in MEGF10, a regulator of satellite cell myogenesis, cause early onset myopathy, areflexia, respiratory distress and dysphagia (EMARDD)","volume":"43","author":"Logan","year":"2011","journal-title":"Nat. Genet."},{"key":"10.1016\/j.ymthe.2025.07.021_bib4","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.15252\/emmm.201505815","article-title":"A POGLUT1 mutation causes a muscular dystrophy with reduced Notch signaling and satellite cell loss","volume":"8","author":"Servi\u00e1n-Morilla","year":"2016","journal-title":"EMBO Mol. Med."},{"key":"10.1016\/j.ymthe.2025.07.021_bib5","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.ajhg.2021.03.020","article-title":"A form of muscular dystrophy associated with pathogenic variants in JAG2","volume":"108","author":"Coppens","year":"2021","journal-title":"Am. J. Hum. Genet."},{"key":"10.1016\/j.ymthe.2025.07.021_bib6","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/mus.27684","article-title":"The Notch signaling pathway in skeletal muscle health and disease","volume":"66","author":"Vargas-Franco","year":"2022","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.ymthe.2025.07.021_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nmd.2024.07.003","article-title":"Three novel missense variants in two families with JAG2-associated limb-girdle muscular dystrophy","volume":"42","author":"Dofash","year":"2024","journal-title":"Neuromuscul. Disord."},{"key":"10.1016\/j.ymthe.2025.07.021_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2024.1414465","article-title":"Case Report: Exploring the clinical spectrum of LGMD R27: insights from a case study with homozygous pathogenic variant in the JAG2 gene","volume":"12","author":"Nikitin","year":"2024","journal-title":"Front. Pediatr."},{"key":"10.1016\/j.ymthe.2025.07.021_bib9","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/j.cell.2015.10.049","article-title":"Jagged 1 Rescues the Duchenne Muscular Dystrophy Phenotype","volume":"163","author":"Vieira","year":"2015","journal-title":"Cell"},{"key":"10.1016\/j.ymthe.2025.07.021_bib10","doi-asserted-by":"crossref","first-page":"4158","DOI":"10.1093\/brain\/awad251","article-title":"MTM1 overexpression prevents and reverts BIN1-related centronuclear myopathy","volume":"146","author":"Giraud","year":"2023","journal-title":"Brain."}],"container-title":["Molecular Therapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500557X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S152500162500557X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,6]],"date-time":"2026-08-06T13:41:19Z","timestamp":1786023679000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S152500162500557X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S152500162500557X"],"URL":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.021","relation":{},"ISSN":["1525-0016"],"issn-type":[{"value":"1525-0016","type":"print"}],"subject":[],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NOTCH2 mutation in centronuclear myopathy: Beyond the scope","name":"articletitle","label":"Article Title"},{"value":"Molecular Therapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.07.021","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/j.ymthe.2025.04.041","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The American Society of Gene and Cell Therapy. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}]}}